INTERNATIONAL NDA / CONFIDENTIALITY AGREEMENT

PREAMBLE

This Non-Disclosure Agreement ("NDA") dated [Date] between [Disclosing Party] and [Receiving Party] protects confidential information shared in connection with [transaction / discussion / evaluation]. Legal Framework: EU Trade Secrets Directive 2016/943 (Art. 1-5), US Defend Trade Secrets Act 18 USC §1836, German UrhG (Copyright Law), BGB §90 (Trade Secrets).

1.1 Definition (per EU Directive 2016/943 Art. 2): Information not publicly known, that (a) has commercial value from being kept secret, (b) subject to reasonable protective measures. Includes:

• Technical data (source code, algorithms, specifications, designs)
• Business information (customer lists, pricing, financial data, strategies)
• Trade secrets (manufacturing processes, formulas, methods)
• Proposals, business plans, market analysis
• Research, development, testing results

1.2 Exclusions: Information that (a) publicly available (not through breach), (b) independently developed, (c) rightfully known before disclosure, (d) legally required to disclose, (e) received from third party with rights to disclose

2.1 Protection Measures: Receiving Party shall protect information using same level of care as own confidential information (minimum reasonable care per BGB §276 (Duty of Care)). Standard: [industry-standard / commercially reasonable / reasonable under circumstances] protective measures
2.2 Permitted Disclosures: Only to employees/agents with (a) legitimate need-to-know, (b) bound by written confidentiality obligations equal to this NDA
2.3 Safeguards: Implement measures including [access controls, encryption, non-disclosure agreements] per GDPR Art. 32 (Security Measures)
2.4 Duration of Confidentiality: [2 / 5 / indefinite for true trade secrets] years per EU Directive Art. 2(2) (no time limit for true trade secrets)

Receiving Party may use information solely for: [evaluate business opportunity, perform due diligence, facilitate transaction, assess partnership]. NO other use without written consent. Prohibition on competitive use, reverse engineering, or disclosure.

4.1 Court Order Disclosure: If legally compelled to disclose (court order, regulatory demand, legal proceeding), Receiving Party shall: (a) notify Discloser immediately (unless prohibited by law) per EU Directive Art. 5(2), (b) cooperate in seeking protective order, (c) disclose minimum information required
4.2 Residual Information: No liability for use of residual information (general knowledge, skills, experience) retained in employees' memory, except trade secrets and confidential information

5.1 Upon Termination: Within [30 days] of request or termination, Receiving Party shall (a) return or destroy all copies of confidential information, (b) certify destruction in writing per UrhG §97
5.2 Exception: One archival copy may be retained if required by law (with continued confidentiality obligations)

6.1 No IP License: Disclosure does NOT grant any license or rights to any intellectual property. Information provided "AS-IS"
6.2 No Warranty: Information provided without warranty of accuracy, completeness, fitness, non-infringement per DTSA Safe Harbor 18 USC §1836(b)(3)(A)
6.3 No Liability: Discloser not liable for errors/omissions in information

7.1 Remedies: Breach may cause irreparable harm. Discloser entitled to: (a) injunctive relief WITHOUT posting bond per DTSA 18 USC §1836(b)(3)(A), (b) damages, (c) attorney fees
7.2 Exemplary Damages: If willful/malicious breach, exemplary damages up to 3x actual damages per DTSA §1836(b)(3)(C)
7.3 No Waiver: Failure to enforce does not waive right

8.1 Immunity Notice (18 USC §1836(b)(3)): Notwithstanding any other provision, employee is NOT liable under federal/state trade secret law for disclosures of trade secrets: (a) made in confidence to government official OR attorney for purpose of reporting/investigating suspected legal violation, (b) made in complaint/filing under seal in legal proceeding, per DTSA 18 USC §1833(b)
8.2 EU Whistleblower Protection: Per EU Whistleblower Protection Directive 2019/1937, employee may disclose confidential information to regulatory authorities/law enforcement without liability

9.1 Non-Circumvention: Receiving Party shall not attempt to circumvent NDA by: (a) disclosing only part of information, (b) disguising information as independently developed, (c) engaging third parties to obtain equivalent information, (d) reverse engineering without authorization per EU Directive Art. 3(2)
9.2 Non-Use for Direct Competition: Receiving Party shall not use information to directly compete with Discloser for [specified period]
9.3 Residual Knowledge Exception: Upon termination, Receiving Party not liable for use of residual knowledge (general skills, experience) retained in unaided memory, except trade secrets strictly defined per EU Directive

10.1 Need-to-Know Disclosures: Receiving Party may disclose to: (a) employees with legitimate business need-to-know, (b) attorneys/advisors for legal/financial advice, (c) accountants/auditors for compliance, (d) lenders/investors with written confidentiality agreements equal to this NDA
10.2 Permitted Recipients: All recipients must be: (a) informed of confidential nature, (b) bound by written confidentiality obligations at least as protective as this NDA, (c) trained on information handling
10.3 Recipient Liability: Receiving Party remains liable for breaches by permitted recipients as if direct breach

11.1 Irreparable Harm: Parties acknowledge breach of this NDA causes irreparable harm not remediable by monetary damages per DTSA 18 USC §1836(b)(3)(A)
11.2 Injunctive Relief: Discloser entitled to seek preliminary injunction (without posting bond) in court of competent jurisdiction to prevent breach/threatened breach
11.3 Non-Exclusive Remedy: Injunctive relief does not preclude other remedies (damages, specific performance)

12.1 Entire Agreement: This NDA constitutes entire agreement regarding confidentiality. Supersedes prior NDAs/discussions unless [prior NDA dated X continues]
12.2 Relationship to Transaction: If contemplated transaction does not proceed, confidentiality obligations continue in full force per EU Directive Art. 1(2)
12.3 Amendment: No modification except in writing signed by both parties
12.4 Severability: If any provision unenforceable, remaining provisions continue in effect

Law: ☐ German law (BGB/UrhG) ☐ [US State] | Disputes: DIS Arbitration or [courts in X]